Enhanced YAP phosphorylation deactivates YAP, suppressing TEAD-mediated target genes such as connective tissue growth factor (CTGF) and CYR61 (Figure 7E), ultimately inhibiting cancer cell proliferation in vitro and reducing ovarian tumor growth in vivo. The gene discussed is CCN2; the disease is cancer.